Updates are available Correction dated 2021-02-01
Click to view Correction: https://doi.org/10.1038/s41408-021-00413-7
Updates are available Correction dated 2021-10-27
Click to view Correction: https://doi.org/10.1038/s41408-021-00567-4
-
Authors
Locatelli, Franco
Zugmaier, Gerhard http://orcid.org/0000-0001-6879-2671
Mergen, Noemi
Bader, Peter
Jeha, Sima
Schlegel, Paul-Gerhardt
Bourquin, Jean-Pierre
Handgretinger, Rupert
Brethon, Benoit
Rossig, Claudia
Chen-Santel, Christiane
- License Information
-
More Information
Article History
Received: 12 February 2020
Revised: 18 June 2020
Accepted: 25 June 2020
First Online: 24 July 2020
Change Date: 27 October 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41408-021-00567-4
Change Date: 1 February 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41408-021-00413-7
Conflict of interest
: F.L. reports speakers’ bureau and consulting fees from Amgen Inc. G.Z. is employed by, holds stock in, and has patents/royalties/other intellectual property with Amgen Inc. N.M. is employed by and holds stock in Amgen Inc. P.B. declares speakers’ bureau fees from Amgen Inc., Novartis, Celgene, Medac, and Servier, and institutional research grants from Riemser, Medac, and Neovii. C.R. reports honoraria and consulting fees from Amgen Inc. Celgene, Novartis, Genentech, and Roche and honoraria from Pfizer, BMS, and Roche. S.J., P.-G.S., J.-P.B., R.H., and B.B. report consulting fees from Amgen Inc., and C.C.-S. has nothing to disclose.
